Heinz Joachim Buettner

Showing 1-8 of 8 articles

The Experts “Live” Workshop of the EuroCTO Club 2017, Berlin

Bufe A, Di Mario C, Landmesser U, Gessner M, Sianos G, Garbo R, Dini C, Lauer B, Boudou N, Grancini L, Avran A, Lauten A, Mashayekhi K, Hildick-Smith D, Escaned J, Buettner H, Reifart N, Lapp H, Galassi A, Werner G

April 20, 2018 | 10.4244/EIJV13I17A324

Clinical implications of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention for chronic total occlusion: role of antegrade and retrograde crossing techniques

Toma A, Stähli B, Gebhard C, Gick M, Minners J, Mashayekhi K, Avran A, Ferenc M, Buettner H, Neumann F

April 20, 2018 | 10.4244/EIJ-D-17-00338

Coronary interventions

Survival after percutaneous coronary intervention for chronic total occlusion in elderly patients

Toma A, Gebhard C, Gick M, Ademaj F, Stähli B, Mashayekhi K, Ferenc M, Neumann F, Buettner H

June 2, 2017 | 10.4244/EIJ-D-16-00499

Long-term outcomes of routine versus provisional T-stenting for de novo coronary bifurcation lesions: five-year results of the Bifurcations Bad Krozingen I study

Ferenc M, Ayoub M, Buettner H, Gick M, Comberg T, Rothe J, Valina C, Hochholzer W, Neumann F

December 20, 2015 | 10.4244/EIJV11I8A175

4D-cardiac CT and IVUS support stenting of left main compression due to an enlarged pulmonary artery

Heidt T, Buettner H, Loffelhardt N, Minners J, Langer M, Neumann F, Bode C, Pache G

December 20, 2015 | 10.4244/EIJV11I8A185

Comparison of bivalirudin and heparin in patients undergoing rotational atherectomy: a subanalysis of the randomised ROTAXUS trial

Akin I, Khattab A, Buettner H, Toelg R, Geist V, Neumann F, Richardt G, Abdel-Wahab M

August 19, 2014 | 10.4244/EIJV10I4A79

Antiplatelet response to the 150-mg maintenance dose of clopidogrel in patients with insufficient platelet inhibition after clopidogrel loading for elective coronary stent placement

Trenk D, Hochholzer W, Müller B, Stratz C, Valina C, Schmiebusch P, Buettner H, Neumann F

August 20, 2008

Prospective non-randomized multi-center evaluation of the non-polymer based ACHIEVE™ Paclitaxel Eluting Coronary Stent System in treatment of lesions with high risk of revascularization due to restenosis: the DELIVER II study

Grube E, Gershlick A, Bartorelli A, Buellesfeld L, Blanchard D, Macaya C, Buettner H, Lim V, Boone E, Dorange C, Marco J

February 20, 2006

1

Latest news

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Management of MR patients undergoing TMVI screening

FREE ARTICLE - Sebastian Ludwig et al.

January 7, 2022

Valvular disease